BioStacks

Amino Acid

5-HTP

Evidence

Limited

Reviewed May 2026

Evidence: 2 of 5 (Limited)

7 studies cited · 1 systematic review

What the evidence says

5-HTP is the direct precursor to serotonin, which converts to melatonin. Crosses the blood-brain barrier readily and is well absorbed orally. Limited sleep-specific RCTs but strong mechanistic basis. Caution: risk of serotonin syndrome when combined with SSRIs, MAOIs, or triptans.

Limited clinical trials for sleep specifically, despite strong mechanistic basis as serotonin precursor

Supports

Stress & MoodLimited
SleepLimited
MetabolismLimited
Show all 4 areas
BrainLimited

Top 5-HTP supplements

2/5

Limited

7

RCTs reviewed

1

Null result

A serotonin precursor with a long history of hype and thin modern evidence. The landmark Cochrane review found only a sliver of usable depression data despite 100+ studies. Sleep evidence is small and often comes from combination products. Appetite/weight and fibromyalgia signals exist but are old and small. Real serotonin-syndrome and contamination risks make this one to use carefully.

Do NOT combine with SSRIs, SNRIs, MAOIs, triptans, tramadol, or other serotonergic drugs — the combination can cause serotonin syndrome, which can be life-threatening.

Research dossier

Clinical research on 5-HTP

7 trials reviewed across 4 indications.

Strongest evidence

Mood & depression

Limited

Mechanism

5-HTP is the immediate precursor to serotonin, crossing the blood-brain barrier and bypassing the rate-limiting tryptophan hydroxylase step. Raising serotonin is the proposed antidepressant mechanism.

The Cochrane review is the honest verdict: of 100+ studies, only two (64 patients) were good enough to use. They favored 5-HTP/tryptophan over placebo, but the evidence was rated too weak to be conclusive, and proven, safer antidepressants exist. Promising precursor logic, badly under-evidenced.

Not a substitute for evidence-based depression treatment. Must never be combined with SSRIs/SNRIs/MAOIs (serotonin syndrome risk).

Trials cited

  • Cochrane review — tryptophan and 5-HTP for depression

    mixed · Systematic review

    Shaw, Turner & Del Mar, 2002, Cochrane Database of Systematic Reviewsn=64

    The definitive review: of 108–111 located studies, only TWO (one 5-HTP, one tryptophan; 64 patients total) met basic quality criteria. Those two favored treatment over placebo (Peto OR 4.1, 95% CI 1.3–13.2) — but the authors judged the evidence too low-quality to be conclusive and noted safer proven antidepressants exist.

    The headline is the attrition: ~106 of ~108 studies were too flawed to use. The positive odds ratio rests on 64 patients and a very wide confidence interval. This is the single most important honesty point about 5-HTP for mood.

    PubMed DOI
Sleep quality

Mechanism

Serotonin is a precursor to melatonin, so raising serotonin could in principle support sleep onset and architecture.

Sleep evidence is thin. The cleanest 5-HTP-alone trial (n=30, single-blind) showed only partial improvement, mostly in poor sleepers. The other commonly cited 'sleep' trial used a 5-HTP + GABA combination, so it can't tell you what 5-HTP does by itself. Modest at best.

Best-case signal is in older poor sleepers. Much of the 'sleep' marketing leans on combination products, not 5-HTP alone.

  • 5-HTP, sleep quality and gut microbiota in older adults

    mixed · RCT

    Sutanto et al., 2024, Clinical Nutritionn=30

    Small parallel RCT in 30 older adults. 100 mg/day improved some sleep-quality components — most visibly in poor sleepers — for up to about 8 weeks, alongside shifts in gut microbiota in poor sleepers.

    Only 30 participants, single-blinded (not double-blind), and benefit was partial and concentrated in a poor-sleeper subgroup. One of the better 5-HTP-alone sleep trials — which says more about how thin the field is than how strong this study is.

    PubMed DOI

  • Amino-acid (5-HTP + GABA) preparation for sleep

    positive · RCT

    Shell et al., 2010, American Journal of Therapeuticsn=18

    A small RCT of a combination amino-acid formula reported shorter time to fall asleep and longer, better-quality sleep versus placebo.

    This is a COMBINATION product (5-HTP plus GABA and other amino acids), so it cannot establish what 5-HTP does on its own. Very small sample. Frequently cited as '5-HTP improves sleep' — it doesn't isolate 5-HTP.

    PubMed DOI
Appetite & weight

Mechanism

Serotonin signaling promotes satiety and reduces carbohydrate intake — the rationale behind 5-HTP as an appetite suppressant.

A small 1992 RCT (n=20) at a high 900 mg/day dose reduced food intake and produced modest weight loss in obese adults. Real but old, small, single-group, and at a dose that commonly causes nausea. Never replicated at scale.

Evidence is limited to obese adults at high doses with notable nausea. Don't expect meaningful weight loss at the low doses sold for sleep/mood.

  • 5-HTP for satiety and weight loss in obese adults

    positive · RCT

    Cangiano et al., 1992, American Journal of Clinical Nutritionn=20

    Double-blind RCT in obese adults: 900 mg/day 5-HTP reduced energy and carbohydrate intake, improved diet adherence, and produced modest weight loss versus placebo.

    Small (n=20), 30+ years old, single research group, and used a high 900 mg/day dose that commonly causes nausea. Never replicated at scale. The early Ceci/Cangiano obesity work is the basis for most 'appetite suppressant' marketing.

    PubMed DOI
Fibromyalgia & migraine

Mechanism

Central serotonin modulates pain processing; serotonin deficiency is implicated in both fibromyalgia and migraine.

Two old positive trials: 5-HTP improved fibromyalgia symptoms (n=50, 30 days) and matched the drug methysergide for migraine prevention (no placebo arm). Both are dated, small, and unreplicated by modern standards. Suggestive, not established.

1980s–90s data only. The migraine trial had no placebo group, so it shows non-inferiority to an old drug, not superiority to placebo.

  • 5-HTP for primary fibromyalgia

    positive · RCT

    Caruso, Sarzi Puttini et al., 1990, Journal of International Medical Researchn=50

    Double-blind placebo-controlled trial in 50 fibromyalgia patients: 300 mg/day improved tender points, pain, morning stiffness, sleep, and fatigue over 30 days, with only mild transient side effects.

    Old (1990), small, single-centre, and short. The authors themselves called for further controlled studies, which never robustly materialized. Not enough to establish 5-HTP as a fibromyalgia treatment.

    PubMed DOI

  • 5-HTP vs methysergide for migraine prophylaxis

    mixed · RCT

    Titus et al., 1986, European Neurologyn=124

    Comparative trial: 5-HTP was roughly as effective as the active drug methysergide for reducing migraine burden, with fewer side effects. Read as 'non-inferior to an old drug,' not as 'beats placebo.'

    Active-comparator design with no placebo arm, so it cannot prove 5-HTP beats placebo. Dated (1986) and not replicated by modern migraine-prophylaxis standards.

    PubMed DOI
Honest-evidence ledger — 1 trial that didn’t move the needle

Surfacing failed trials alongside the positive evidence. Leaving them out would be marketing, not science.

  • Peak X contaminants in commercial 5-HTP

    negative · Observational

    Klarskov, Johnson et al., 1999/2003, Eosinophilia-myalgia-associated contaminant analysis

    Analytical work confirmed that commercially available 5-HTP can contain 'Peak X' — a family of contaminants (molecular weight ~234 Da) related to those implicated in the deadly 1989 eosinophilia-myalgia syndrome (EMS) epidemic tied to contaminated L-tryptophan.

    This is a safety/quality finding, not an efficacy trial. It documents why 5-HTP carries a contamination concern and why third-party testing matters. EMS killed dozens and sickened over 1,300 in the L-tryptophan epidemic.

    PubMed DOI
3 forms of 5-HTP compared

  • 5-HTP (5-hydroxytryptophan), free-form

    Crosses the blood-brain barrier; ~50–70% reaches systemic circulation

    Best forMood, sleep, appetite

    Unlike L-tryptophan, 5-HTP does not require active transport and is not diverted into the kynurenine/niacin pathway, so it converts to serotonin more directly. Standard caps are 50–100 mg.

  • Griffonia simplicifolia

    Griffonia simplicifolia seed extract

    Same active molecule (5-HTP) as synthetic; depends on standardized 5-HTP content

    Best forThe natural commercial source of 5-HTP

    Virtually all commercial 5-HTP is extracted from the seeds of the West African plant Griffonia simplicifolia. Look for the standardized 5-HTP content on the label, and prefer third-party-tested product given the Peak X contamination history.

  • 5-HTP + GABA combination

    Variable; depends on the individual ingredients

    Best forSleep blends

    Common in sleep formulas. Be aware that the trial often cited for '5-HTP and sleep' used this combination — so it does not prove 5-HTP works on its own.

Side effects and drug interactions

Side effects

  • Nausea and GI upset

    Common · More common at 300 mg/day and above; pronounced at the 900 mg/day used in weight trials

    The most common side effect, driven by peripheral serotonin in the gut. Worse at higher doses and when started without titration.

    Gentler:5-htp

  • Serotonin syndrome

    Severe

    Excess serotonergic activity causing agitation, rapid heart rate, high blood pressure, tremor, sweating, hyperthermia, and in severe cases seizures or death. The risk is real and rises sharply when 5-HTP is combined with other serotonergic agents.

  • Drowsiness

    Uncommon

    Sedation, especially at higher doses or when combined with other calming agents.

  • Pediatric agitation

    Uncommon

    In children with behavioral or mood disorders, 100 mg twice daily triggered agitation in about 20% of at-risk children in clinical studies, requiring a reduction to 100 mg/day. Use with extreme caution in children.

  • Eosinophilia-myalgia syndrome (EMS) — contamination-linked

    Rare

    A rare but serious illness (severe muscle pain, high eosinophils, skin and connective-tissue changes) historically tied to a 'Peak X' contaminant. The deadly 1989 epidemic was traced to contaminated L-tryptophan, and Peak X has since been detected in some commercial 5-HTP. The herb's intrinsic risk is debated, but the contamination concern is documented.

    Gentler:griffonia simplicifolia extract

Drug interactions

  • Combined-effect risk

    SSRIs (sertraline, fluoxetine, escitalopram)SNRIs (venlafaxine, duloxetine)MAOIs (phenelzine, selegiline)tricyclic antidepressantstriptans (sumatriptan)tramadolSt. John's Wortdextromethorphan

    All increase serotonergic activity. Stacking 5-HTP on top raises the risk of serotonin syndrome — additive, not offsetting. (Documented human serotonin-syndrome cases trace to L-tryptophan combinations rather than 5-HTP itself, but the mechanistic risk applies — the rule stands.)

    Do not combine 5-HTP with any of these without explicit medical supervision. This is the single most important interaction for 5-HTP.

  • Combined-effect risk

    carbidopa

    Carbidopa (a peripheral decarboxylase inhibitor) raises 5-HTP's central availability. Case reports linked high-dose 5-HTP plus carbidopa with scleroderma-like skin changes, though causality was not firmly established.

    The 5-HTP + carbidopa combination should only be used under specialist neurological supervision.

  • Additive effect

    sedativesbenzodiazepinesalcohol

    Additive sedation.

    Use caution combining with other CNS depressants.

Other critical caveats
  • Never combine 5-HTP with SSRIs, SNRIs, MAOIs, tricyclics, triptans, tramadol, St. John's Wort, or dextromethorphan. The combination can trigger serotonin syndrome, which can be fatal. This is the most important thing to know about 5-HTP.
  • The Cochrane review found that of 100+ depression studies, only two (64 patients) were methodologically sound enough to use. The popular 'natural antidepressant' framing rests on a very thin evidence base.
  • 5-HTP carries a contamination history: the 'Peak X' family of contaminants — related to those behind the deadly 1989 eosinophilia-myalgia syndrome (EMS) epidemic from contaminated L-tryptophan (>1,300 cases, dozens of deaths) — has been detected in some commercial 5-HTP. Buy only third-party-tested product.
  • Much of the '5-HTP helps sleep' marketing relies on combination products (e.g. 5-HTP + GABA), which cannot show what 5-HTP does on its own. The 5-HTP-alone sleep evidence is small and only partially positive.
  • Do not use in pregnancy, while breastfeeding, or before surgery, and avoid in people with a history of EMS or scleroderma-like illness.
  • 5-HTP raises urinary 5-HIAA, the screening marker for carcinoid syndrome. Tell your provider you take 5-HTP before a 24-hour urine 5-HIAA test, so a false-positive result isn't misread as a tumor.
Frequently asked
  • Does 5-HTP work as a natural antidepressant?
    The honest answer is 'we don't really know.' The Cochrane review found that out of 100+ studies, only two (64 patients total) were good enough to analyze. They leaned positive but were rated too low-quality to be conclusive, and proven, safer antidepressants already exist. Treat it as an under-evidenced precursor, not a validated treatment — and never stack it on an SSRI.
  • Is it safe to take 5-HTP with my antidepressant?
    No — this is the key safety rule. Combining 5-HTP with SSRIs, SNRIs, MAOIs, tricyclics, triptans, tramadol, or St. John's Wort can cause serotonin syndrome, a potentially life-threatening reaction. Do not combine them without explicit medical supervision.
  • Will 5-HTP help me sleep?
    Maybe modestly, especially if you're an older poor sleeper. The cleanest 5-HTP-alone trial (30 people) showed only partial improvement. The other widely cited 'sleep' study used a 5-HTP + GABA combination, so it can't tell you what 5-HTP does by itself. Don't expect a dramatic effect.
  • What about the contamination scare — is 5-HTP dangerous?
    There's a real history here. A 'Peak X' contaminant related to the one behind the deadly 1989 eosinophilia-myalgia syndrome epidemic (from contaminated L-tryptophan) has been found in some commercial 5-HTP. The herb's own intrinsic risk is debated, but the contamination concern is documented — so only buy third-party-tested product.
  • How much should I take and what form?
    Almost all 5-HTP comes from Griffonia simplicifolia seeds. Sleep/mood doses are typically 50–300 mg/day; start low (50–100 mg) because nausea is common, and take it later in the day for sleep. To minimize nausea, split the daily total into 3–4 smaller doses — 5-HTP has a short half-life, so dosing frequency matters for tolerability. The weight-loss trials used a much higher 900 mg/day, which causes significant nausea. Choose a third-party-tested product.
  • Can 5-HTP help with opioid withdrawal?
    It's been proposed, but there are no controlled trials supporting it — this is purely investigational and not a reason to use 5-HTP. Don't rely on it for withdrawal; seek proper medical care.

References

  1. 01Shaw, Turner & Del Mar, 2002 — Tryptophan and 5-HTP for depression (Cochrane)
  2. 02Sutanto et al., 2024 — 5-HTP, sleep quality and gut microbiota in older adults, RCT (Clinical Nutrition)
  3. 03Cangiano et al., 1992 — 5-HTP, satiety and weight loss, RCT (Am J Clin Nutr)
  4. 04Klarskov et al., 2000 — EMS-associated contaminants in commercial 5-HTP (Anal Biochem)
  5. 05Examine.com — 5-HTP

Last reviewed2026-05-24